AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 16 filers reported holding AEGERION PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 3.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $369,000 | -10.4% | 550,000 | 0.0% | 0.00% | – |
| Q4 2018 | $412,000 | 0.0% | 550,000 | 0.0% | 0.00% | – |
| Q3 2018 | $412,000 | +33.8% | 550,000 | +15.8% | 0.00% | – |
| Q2 2018 | $308,000 | -42.9% | 475,000 | -32.1% | 0.00% | – |
| Q1 2018 | $539,000 | -10.6% | 700,000 | -7.7% | 0.00% | – |
| Q4 2017 | $603,000 | +0.3% | 758,000 | 0.0% | 0.00% | – |
| Q3 2017 | $601,000 | +32.7% | 758,000 | +35.8% | 0.00% | – |
| Q2 2017 | $453,000 | +74.2% | 558,000 | +71.7% | 0.00% | – |
| Q1 2017 | $260,000 | – | 325,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 1,500,000 | $1,219,000 | 0.82% |
| EdgePoint Investment Group Inc. | 51,642,000 | $41,704,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 16,600,000 | $13,359,000 | 0.60% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 43,150,000 | $34,952,000 | 0.52% |
| Tekla Capital Management LLC | 13,000,000 | $10,303,000 | 0.37% |
| UBS OCONNOR LLC | 26,000,000 | $20,669,000,000 | 0.30% |
| Orbimed Advisors | 15,000,000 | $12,151,000 | 0.12% |
| Baker Brothers Advisors | 9,517,000 | $7,576,000 | 0.06% |
| CSS LLC/IL | 653,000 | $517,000 | 0.02% |
| Allianz Asset Management GmbH | 28,680,000 | $23,232,000 | 0.02% |